No Data
No Data
Huaxia Ophthalmology: Semi-Annual Report 2024
Huaxia Ophthalmology: 2024 Semi-Annual Report Summary
Huaxia Ophthalmology (301267.SZ) released its half-year performance, with a net income of 0.265 billion yuan, a decrease of 25.15%.
Hua Xia Ophthalmology (301267.SZ) released its 2024 interim report, with revenue of 20.51...
Huaxia Ophthalmology (301267.SZ): The net income in the first half of the year was 0.265 billion yuan, a year-on-year decrease of 25.15%.
Hua Xia Ophthalmology (301267.SZ) announced its semi-annual report for 2024, with a revenue of 2.051 billion yuan, a year-on-year increase of 2.85%; a net income of 0.265 billion yuan attributable to shareholders of listed companies, a year-on-year decrease of 25.15%; a net income of 0.271 billion yuan attributable to shareholders of listed companies, after deducting non-recurring gains and losses, a year-on-year decrease of 25.22%; and a basic earnings per share of 0.32 yuan.
Huaxia Eye Hospital Group Co.,Ltd.'s (SZSE:301267) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Huaxia Ophthalmology (301267.SZ): No products related to AI glasses have been involved yet.
Huaxia Ophthalmology (301267.SZ) stated on the investor interaction platform on August 15 that the company's main business is medical services in ophthalmology, and it has not yet involved products such as AI glasses.
No Data